Literature DB >> 32265321

Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Delphine Fontaine1, Sandy Figiel1, Romain Félix1, Sana Kouba1, Gaëlle Fromont2, Karine Mahéo3, Marie Potier-Cartereau1, Aurélie Chantôme3, Christophe Vandier4.   

Abstract

Ether lipids (ELs) are lipids characterized by the presence of either an ether linkage (alkyl lipids) or a vinyl ether linkage [i.e., plasmalogens (Pls)] at the sn1 position of the glycerol backbone, and they are enriched in PUFAs at the sn2 position. In this review, we highlight that ELs have various biological functions, act as a reservoir for second messengers (such as PUFAs) and have roles in many diseases. Some of the biological effects of ELs may be associated with their ability to regulate ion channels that control excitation-contraction/secretion/mobility coupling and therefore cell physiology. These channels are embedded in lipid membranes, and lipids can regulate their activities directly or indirectly as second messengers or by incorporating into membranes. Interestingly, ELs and EL-derived PUFAs have been reported to play a key role in several pathologies, including neurological disorders, cardiovascular diseases, and cancers. Investigations leading to a better understanding of their mechanisms of action in pathologies have opened a new field in cancer research. In summary, newly identified lipid regulators of ion channels, such as ELs and PUFAs, may represent valuable targets to improve disease diagnosis and advance the development of new therapeutic strategies for managing a range of diseases and conditions.
Copyright © 2020 Fontaine et al.

Entities:  

Keywords:  cancer; cardiovascular disease; cell membrane; metastasis; neurodegeneration; neurological disorder; polyunsaturated fatty acids

Mesh:

Substances:

Year:  2020        PMID: 32265321      PMCID: PMC7269763          DOI: 10.1194/jlr.RA120000634

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  234 in total

1.  Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects.

Authors:  S Hardy; Y Langelier; M Prentki
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

2.  Reducing endothelial NOS activation and interstitial fluid pressure with n-3 PUFA offset tumor chemoresistance.

Authors:  Sophie Kornfeld; Caroline Goupille; Sophie Vibet; Stephan Chevalier; Amandine Pinet; Justine Lebeau; François Tranquart; Philippe Bougnoux; Eric Martel; Anne Maurin; Serge Richard; Pascal Champeroux; Karine Mahéo
Journal:  Carcinogenesis       Date:  2011-11-23       Impact factor: 4.944

3.  Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis.

Authors:  Eva Cífková; Michal Holčapek; Miroslav Lísa; David Vrána; Jiří Gatěk; Bohuslav Melichar
Journal:  Anal Bioanal Chem       Date:  2014-10-29       Impact factor: 4.142

4.  N-3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France.

Authors:  Virginie Maillard; Philippe Bougnoux; Pietro Ferrari; Marie-Lise Jourdan; Michelle Pinault; Flore Lavillonnière; Gilles Body; Olivier Le Floch; Véronique Chajès
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

5.  Role of ether-linked lysophosphatidic acids in ovarian cancer cells.

Authors:  Jun Lu; Yi-jin Xiao Yj; Linnea M Baudhuin; Guiying Hong; Yan Xu
Journal:  J Lipid Res       Date:  2002-03       Impact factor: 5.922

6.  Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity.

Authors:  Daniel I Benjamin; Alyssa Cozzo; Xiaodan Ji; Lindsay S Roberts; Sharon M Louie; Melinda M Mulvihill; Kunxin Luo; Daniel K Nomura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 7.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

8.  Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients.

Authors:  Juergen Graessler; Dominik Schwudke; Peter E H Schwarz; Ronny Herzog; Andrej Shevchenko; Stefan R Bornstein
Journal:  PLoS One       Date:  2009-07-15       Impact factor: 3.240

9.  The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53.

Authors:  Soyeon Shin; Kaipeng Jing; Soyeon Jeong; Nayeong Kim; Kyoung-Sub Song; Jun-Young Heo; Ji-Hoon Park; Kang-Sik Seo; Jeongsu Han; Jong-Il Park; Gi-Ryang Kweon; Seung-Kiel Park; Tong Wu; Byung-Doo Hwang; Kyu Lim
Journal:  Biomed Res Int       Date:  2013-06-10       Impact factor: 3.411

10.  Ca2+ protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity.

Authors:  Yann Fourbon; Maxime Guéguinou; Romain Félix; Bruno Constantin; Arnaud Uguen; Gaëlle Fromont; Laurie Lajoie; Christophe Magaud; Thierry Lecomte; Emmanuel Chamorey; Aurélien Chatelier; Olivier Mignen; Marie Potier-Cartereau; Aurélie Chantôme; Patrick Bois; Christophe Vandier
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

View more
  6 in total

1.  THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.

Authors:  Arnaud Blomme; Coralie Peter; Ernest Mui; Giovanny Rodriguez Blanco; Ning An; Louise M Mason; Lauren E Jamieson; Grace H McGregor; Sergio Lilla; Chara Ntala; Rachana Patel; Marc Thiry; Sonia H Y Kung; Marine Leclercq; Catriona A Ford; Linda K Rushworth; David J McGarry; Susan Mason; Peter Repiscak; Colin Nixon; Mark J Salji; Elke Markert; Gillian M MacKay; Jurre J Kamphorst; Duncan Graham; Karen Faulds; Ladan Fazli; Martin E Gleave; Edward Avezov; Joanne Edwards; Huabing Yin; David Sumpton; Karen Blyth; Pierre Close; Daniel J Murphy; Sara Zanivan; Hing Y Leung
Journal:  EMBO Mol Med       Date:  2022-01-11       Impact factor: 12.137

2.  Development of a High-Performance Thin-Layer Chromatography Method for the Quantification of Alkyl Glycerolipids and Alkenyl Glycerolipids from Shark and Chimera Oils and Tissues.

Authors:  Marion Papin; Cyrille Guimaraes; Benoit Pierre-Aue; Delphine Fontaine; Jeoffrey Pardessus; Hélène Couthon; Gaëlle Fromont; Karine Mahéo; Aurélie Chantôme; Christophe Vandier; Michelle Pinault
Journal:  Mar Drugs       Date:  2022-04-18       Impact factor: 6.085

3.  Plasmalogen-Based Liquid Crystalline Multiphase Structures Involving Docosapentaenoyl Derivatives Inspired by Biological Cubic Membranes.

Authors:  Angelina Angelova; Borislav Angelov; Markus Drechsler; Thomas Bizien; Yulia E Gorshkova; Yuru Deng
Journal:  Front Cell Dev Biol       Date:  2021-02-11

Review 4.  Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Isabella Wimmer; Johannes Berger
Journal:  Neurobiol Dis       Date:  2020-08-28       Impact factor: 5.996

Review 5.  The Protein Toxins Ricin and Shiga Toxin as Tools to Explore Cellular Mechanisms of Internalization and Intracellular Transport.

Authors:  Kirsten Sandvig; Simona Kavaliauskiene; Tore Skotland
Journal:  Toxins (Basel)       Date:  2021-05-25       Impact factor: 4.546

6.  Alterations in complex lipids in tumor tissue of patients with colorectal cancer.

Authors:  Alicja Pakiet; Kinga Sikora; Jarek Kobiela; Olga Rostkowska; Adriana Mika; Tomasz Sledzinski
Journal:  Lipids Health Dis       Date:  2021-08-04       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.